GenómicaPUBLICACIONES

LÍNEA CLART®CMA

1. "NRAS and KRAS testing by a new diagnostic method to detect point mutations in colorectal cancer specimens: Clart-NRAS iKRAS".

Maria Luisa Villahermosa, Juan Moscoso del Prado, Nuria Manjon, Ana Isabel Moraga, Maria Jesus Sanz, Javier Hernandez-Losa, Javier Gomez-Roman, Jesper Bonde, Jose Luis Rodriguez-Peralto, Rosario Cospedal

May 2014, Journal of Clinical Oncology

 

2.EGFR testing by a new diagnostic method to detect point mutations, deletions and insertions associated to non small cell lung cancer: CLART CMA EGFR.

Maria Jesus Sanz, Nuria Manjon, Ana Aragon, Juan Moscoso del Prado, Jose Luis Rodriguez-Peralto, Javier Hernandez-Losa, Julian Sanz, Javier Gomez-Roman, Michele Biscuola, Enrique Alava, Rosario Cospedal, Maria Luisa Villahermosa

May 2015, Journal of Clinical Oncology

 

3. "BRAF, MEK1, AKT1 testing by a new diagnostic method to detect point mutations associated with melanoma: CLART CMA BRAF-MEK1-AKT1".

Authors:

Maria Jesus Sanz, Marta Sanchez, Jaime Martinez, Gonzalo Garcia, Ines Mora, Nuria Manjon, Yolanda Ruano, Jose Luis Rodriguez-Peralto, Rosario Cospedal, Maria Luisa Villahermosa;

May 2016, Journal of Clinical Oncology

 

4. "RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas".

Serrano C1, Romagosa C2, Hernández-Losa J2, Simonetti S2, Valverde C1, Moliné T2, Somoza R2, Pérez M3, Vélez R3, Vergés R4, Domínguez R5, Carles J1, Ramón Y Cajal S2. Cancer. 2016 Jan 1;122(1):99-107. doi: 10.1002/cncr.29733. Epub 2015 Oct 19.

 

CLART® HPV2


1."Clinical Performance of the CLART® Human Papillomavirus 2 Assay Compared With the Hybrid Capture 2 Test". Angela Pista, Nuno Verdasca and Ana Oliveira. Journal of Medical Virology 2011 83:272-276 (2011).
http://www.ncbi.nlm.nih.gov/pubmed/21181922


2."External quality assessment for molecular detection of human papillomaviruses". Elizabeth J.Fagana, CatherineMooreb, ClaireJenkinsa,c, AnnelineRossouwa, Heather A.Cubieb, VivienneL.A.Jamesa, Journal of Clinical Virology 48 (2010) 251-254.
http://www.ncbi.nlm.nih.gov/pubmed/20542463


3."HPV DNA genotyping vs. cytology in a population of 50.000 women as a part of cervical cancer prevention program". Doménech G.1, De los Ríos R., González M.J., Acítores C.1, Tamames S., Salazar O., Villahermosa M. L., Cospedal R. and Castrodeza Sanz J. J. Presented on the 26th IPC, Montreal 2010.


4. "High frequency of multiple HPV types in cervical specimens from Danish women". Nina Mejlhede, Jesper Bonde, Anders Fomsgaard. APMIS 2009, 117: 108-114.
http://www.ncbi.nlm.nih.gov/pubmed/19239432


5. "Prevalence of HPV Infection among females in the United States". Eileen F. Dunne; Elizabeth R. Unger; Maya Sternberg; et al. JAMA. 2007; 297(8):813-81.
http://www.ncbi.nlm.nih.gov/pubmed/17327523


6. "Characterisation of human papillomavirus (HPV) genotypes in the Azorean population, Terceira island". Dutra I, Santos MR, Soares M, Couto AR, Bruges-Armas M, Teixeira F, Monjardino L, Hodgson S, Bruges-Armas J. Infect Agent Cancer. 2008 Apr 21;3:6.
http://www.ncbi.nlm.nih.gov/pubmed/18426589


7. "Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko Equatorial Guinea".García-Espinosa B, Nieto-Bona MP, Rueda S, Silva-Sánchez LF, Piernas-Morales MC, Carro-Campos P, Cortés-Lambea L, Moro-Rodríguez E. Diagn Pathol. 2009 Sep 9;4:31.
http://www.ncbi.nlm.nih.gov/pubmed/19740435


8. "HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model". Fuste P, Bellosillo B, Santamaria X, Mancebo G, Mariñoso L, Alameda F, Espinet B, Sole F, Serrano S, Carreras R. Int J Gynecol Pathol. 2009 Mar;28(2):120-6.
http://www.ncbi.nlm.nih.gov/pubmed/19188824


9. "Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study".Cobo F, Concha A, Ortiz M. Open Virol J. 2009 Sep 4;3:60-6.
http://www.ncbi.nlm.nih.gov/pubmed/19750125


10. "A type-specific study of human papillomavirus prevalence in cervicovaginal samples in three different Spanish regions." Gomez-Roman JJ, Echevarria C, Salas S, González-Morán MA, Perez-Mies B, García-Higuera I, Nicolás Martínez M, Val-Bernal JF. APMIS. 2009 Jan;117(1):22-7.
http://www.ncbi.nlm.nih.gov/pubmed/19161533


CLART® PneumoVir


1. “Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system.

Antoine Huguenin, Lauryane Moutte, Fanny Renois, Nicolas Leveque, Deborah Talmud, Michel Abely, Yohan Nguyen, Fabrice Carrat, and Laurent Andreoletti.  Journal of Medical Virology 84:979–985 (2012).

 

2. “Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays”.

S. Kouni, P. Karakitsos, A. Chranioti, M. Theodoridou, G. Chrousos and A. Michos. Clinical Microbiology and Infection 10.1111/1469-0691.12015.

 

3. "Rapid Detection of Respiratory Tract Viral infections and Coinfections in Patients with Influenzalike Illnesses by Use of RT-PCR DNA Microarray Systems". Fanny Renois, Déborah Talmud , Antoine Huguenin , Lauryane Moutte, Christophe Strady, Joel Cousson, Nicolas Lévíque and Laurent Andréoletti*. J. Clin. Microbiol. doi:10.1128/JCM.00733-10.
http://www.ncbi.nlm.nih.gov/pubmed/20739481


4. "Characterization of viruses causing Human Respiratory Infections via Genomic Identification for in vitro diagnosis. CLINICAL ARRAYS/CLART PneumoVir". Alemán A., Marcos MA, Pena MJ, Muir P, Vipond B, Macías A, Villahermosa ML. Poster Session at ECCMID 2008, Barcelona.


5. "An Innovative Low density Array for the Multiple Detection of Respiratory Viruses". J. Maslin, P. Bigot, T. Gaillard, C. Martinaud, G. Menard, P. Brisou. Presented at: 15 th International Symposium on HIV and Emerging Infectious Diseases. May 2008, Toulon, France.


6. "Respiratory viruses in children admitted to hospital intensive care units: evaluating the CLART® Pneumovir DNA array". Frobert E, Escuret V, Javouhey E, Casalegno JS, Bouscambert-Duchamp M, Moulinier C, Gillet Y, Lina B, Floret D, Morfin F.. Journal of Medical Virology 2011 Jan; 83(1):150-5.
http://www.ncbi.nlm.nih.gov/pubmed/21108353


CLART® ENTHERPEX


1. “The microarray technology: facts and controversies

N. Leveque, F. Renois  and L. Andreoletti. Clinical Microbiology and Infection. 10.1111/1469-0691.12024.

 

2. "LíHHV7 : co-facteur des infections méningées á entérovirus?" Adrien Van Haecke, Amélie Sandré, Lauryane Moutte, Antoine Huguenin, Fanny Renois, Christophe De Champ, Véronique Brodard, Laurent Andréoletti, Nicolas Lévíque. Presented at RICAI 2009.


3. "Evaluation of a new commercial PCR-DNA microarray for rapid and simultaneous detection of 9 viruses responsible for central nervous system infections". Nicolas Leveque, Adrien Van Haecke, Fanny Renois, Laurent Andreoletti.


4. "Combining Multiplex Reverse Transcription-PCR and a Diagnostic Microarray to Detect and Differentiate Enterovirus 71 and Coxsackievirus A16". Tsan-Chi Chen, Guang-Wu Chen, Chao Agnes Hsiung, Jyh-Yuan Yang, Shin-Ru Shih, Yiu-Kay Lai, Jyh-Lyh Juang. Journal of Clinical Microbiology. 44(6), 2212-2219 (2006).
http://www.ncbi.nlm.nih.gov/pubmed/16757623


5. "DNA microarrays for virus detection in cases of central nervous system infection". Boriskin YS, Rice PS, Stabler RA, Hinds J, Al-Ghusein H, Vass K, Butcher PD. . Journal of Clinical Microbiology. 42(12), 5811-5818 (2004).
http://www.ncbi.nlm.nih.gov/pubmed/15583316


CLART® MetaBone


1. "The presence of a polymorphism at the traslation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women". Coleman et al. Journal of Bone and Mineral Research (1996) 11, 12, 1850-1855.
http://www.ncbi.nlm.nih.gov/pubmed/8970885


2. "Meta-Analysis of Col1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture". Mann V., Ralston SH. Bone (2003). 32 (6):711-717.
http://www.ncbi.nlm.nih.gov/pubmed/12810179


3. "Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy". Journal of Bone and Mineral Research, Salmen et al. 15 (2000) (2): 315-321.
http://www.ncbi.nlm.nih.gov/pubmed/10703934


4. "Association of CTR and col1A1 alleles with BMD values in peri and post-menopausal women". Calcif Tissue Int. Braga et al. (2000) 67, 361-366.
http://www.ncbi.nlm.nih.gov/pubmed/11136533


5. "Estudio de validación en pacientes con osteoporosis de una técnica por secuenciación frente al análisis por "Array en tubo" para un panel de polimorfismos genéticos con implicación en la densidad mineral ósea". Mª Luisa Villahermosa, Jose Espinoza, Pilar Llamas, Aranzazu García Raso, Ana Drozdowskyj, Marjorie Andrade, M Díaz Curiel. Poster Session at SEIOMM 2006, Málaga (Spain)


6. "Polimorfismos del gen receptor alfa de estrógenos en pacientes con fractura osteoporótica". Jose Espinoza Pineda, Mª Luisa Villahermosa, Ana Drozdowskyj, Marjorie Andrade Pilar Llamas, M Díaz Curiel. Poster Session at SEIOMM 2006, Málaga (Spain)


7. "Estudio de la prevalencia de los polimorfismos del receptor de la calcitonina (CTR) en mujeres postmenopáusicas con fracturas osteoporóticas" Jose Espinoza Pineda, Mª Luisa Villahermosa, Pilar Llamas, Ana Drozdowskyj, Marjorie Andrade, Aranzazu García Raso, M Díaz Curiel. Poster Session at SEIOMM 2006, Málaga (Spain)


8. "Prevalencia de los polimorfismos del COL-1A1 en una población de mujeres postmenopáusicas con fracturas osteoporóticas". Jose Espinoza Pineda, Mª Luisa Villahermosa, Pilar Llamas, Ana Drozdowskyj, Mª Jesus Moro Álvarez, M Díaz Curiel. Poster Session at SEIOMM 2006, Málaga (Spain)


9. "Anomalías del gen receptor de la vitamina D y osteoporosis" Jose Espinoza Pineda, Mª Luisa Villahermosa, Pilar Llamas, Ana Drozdowskyj, Mª Jesus Moro Álvarez Aranzazu García Raso, M Díaz Curiel. Poster Session at SEIOMM 2006, Málaga (Spain)


CLART® SeptiBac+

 

1. ”Hemocultivos”. 2nd Ed. (3a). Loza E., Planes A. y M. Rodriguez . Eds. Cercenado E. y R. Cantón. Procedimientos en Microbiología Clínica. Sociedad Española de Microbiologia Clínica, SEIMC (2003).

 

2. “Diseño y optimización de un sistema de detección molecular por microarrays para la rápida identificación de bacterias grampositivas y hongos en hemocultivos positivos”. Moraga A. I., Salazar, O., Jordana LLuch E., Martró E., Molinos, S., Giménez M., Cospedal R., Ausina, V., y M. L. Villahermosa. Enfermedades Infecciosas y Microbiología Clínica. Vol 29, 33-34 (2011). 15th Congreso de la Sociedad Española de Microbiología Clínica (SEIMC). Malaga, 1-4 Junio 2011.


CLART® EnteroBac


1. ”Diagnóstico microbiológico de infecciones gastrointestinales”. 2nd Ed. (24). Alvarez, M., Buesa, J., Castillo. J. y J. Vila. Eds. Cercenado E. y R. Cantón. Procedimientos en Microbiología Clínica. Sociedad Española de Microbiologia Clínica, SEIMC (2007).

 

2. “Diseño y optimización de un sistema rápido por multiplex-PCR e hibridación en microarray para la detección e identificación de patógenos bacterianos en pacientes con diarrea”. Manjón, N., Moscoso, J., Margolles, Y., García, M., Morosini, M. I., Salazar, O., Cospedal R., Cantón, R., y M. L. Villahermosa. Enfermedades Infecciosas y Microbiología Clínica. Vol 29, 33-34 (2011). 15th Congreso de la Sociedad Española de Microbiología Clínica (SEIMC). Malaga, 1-4 Junio 2011.

 


Publicaciones